Adocia SA (EPA:ADOC)
4.110
+0.010 (0.24%)
Jun 23, 2026, 5:35 PM CET
Adocia Market Cap
Adocia has a market cap or net worth of €80.42 million as of June 23, 2026. Its market cap has increased by 23.11% in one year.
Market Cap
80.42M
Enterprise Value
72.06M
Revenue
3.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.11
Market Cap Chart
Since February 20, 2012, Adocia's market cap has decreased from 93.74M to 80.42M, a decrease of -14.21%. That is a compound annual growth rate of -1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 80.42M | -38.62% |
| Dec 31, 2025 | 131.01M | 40.99% |
| Dec 31, 2024 | 92.92M | -42.69% |
| Dec 29, 2023 | 162.13M | 379.37% |
| Dec 30, 2022 | 33.82M | -41.93% |
| Dec 31, 2021 | 58.24M | 1.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transgene | 204.59M |
| Cellectis | 193.85M |
| Innate Pharma | 150.88M |
| Sensorion | 132.54M |
| Valerio Therapeutics Société anonyme | 103.39M |
| OSE Immunotherapeutics | 82.13M |
| ABIONYX Pharma | 77.47M |
| MaaT Pharma | 53.80M |